Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
8.31M
-
Shares change
-
+216K
-
Total reported value, excl. options
-
$72M
-
Value change
-
-$2.03M
-
Put/Call ratio
-
0.44
-
Number of buys
-
39
-
Number of sells
-
-49
-
Price
-
$8.65
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2022
131 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q1 2022.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.31M shares
of 41M outstanding shares and own 20.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.83M shares), TWO SIGMA ADVISERS, LP (662K shares), TWO SIGMA INVESTMENTS, LP (551K shares), STATE STREET CORP (538K shares), Assenagon Asset Management S.A. (385K shares), MILLENNIUM MANAGEMENT LLC (364K shares), VANGUARD GROUP INC (337K shares), GEODE CAPITAL MANAGEMENT, LLC (321K shares), MORGAN JESS S & CO INC (291K shares), and NORTHERN TRUST CORP (282K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.